ZFYVE27 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA529034-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA529034 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
ZFYVE27
Classification
Polyclonal
Conjugate
Unconjugated
Gene
ZFYVE27
Gene Alias
2210011N02Rik; 9530077C24Rik; AI426636; AI593546; AI835681; im:7137347; LOW QUALITY PROTEIN: protrudin; PROTRUDIN; RP11-459F3.2; Spastic paraplegia 33 protein; SPG33; zfyve27; zgc:153156; zinc finger FYVE domain containing 27; zinc finger FYVE domain-containing protein 27; zinc finger FYVE-type containing 27; zinc finger, FYVE domain containing 27; zinc finger, FYVE domain containing 27 isoform c
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
118813
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7
Gene Accession No.
Q5T4F4
Gene Symbols
ZFYVE27
Immunogen
Recombinant fragment corresponding to a region within amino acids 166 and 411 of Human ZFYVE27
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Recommended positive controls: NT2D1, PC-3, U87-MG, SK-N-SH
- Predicted reactivity: Mouse (86%), Rat (83%), Bovine (88%)
- Store product as a concentrated solution
- Centrifuge briefly prior to opening the vial
- This gene encodes a protein with several transmembrane domains, a Rab11-binding domain and a lipid-binding FYVE finger domain
- The encoded protein appears to promote neurite formation
- A mutation in this gene has been reported to be associated with hereditary spastic paraplegia, however the pathogenicity of the mutation, which may simply represent a polymorphism, is unclear.